Label: FAMOTIDINE injection

  • NDC Code(s): 70771-1845-1, 70771-1845-7, 70771-1846-1, 70771-1846-6, view more
    70771-1847-1, 70771-1847-6
  • Packager: Zydus Lifesciences Limited
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated August 2, 2023

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    NDC 70771-1846-6

    Famotidine Injection USP, 40 mg/4 mL (10 mg/mL)

    FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

    10 X 4 mL Multiple-Dose Vials

     

    Rx Only

    40 mg/4 mL (10 mg/mL) carton label

    NDC 70771-1846-1

    Famotidine Injection USP, 40 mg/4 mL (10 mg/mL)

    FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

    4 mL Multiple-Dose Vials

    Rx only

    40 mg/4 mL (10 mg/mL) vial label

    NDC 70771-1847-6

    Famotidine Injection USP, 200 mg/20 mL (10 mg/mL)

    FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

    10 X 20 mL Multiple-Dose Vials

    Rx only

    200 mg/20 mL (10 mg/mL) carton label

    NDC 70771-1847-1

    Famotidine Injection USP, 200 mg/20 mL (10 mg/mL)

    FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

    20 mL Multiple-Dose Vials

    Rx only

    200 mg/20 mL (10 mg/mL) vial label

    NDC 70771-1845-7

    Famotidine Injection USP, 20 mg/2 mL (10 mg/mL)

    FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

    25 X 2 mL Single-Dose Vials

    Rx only

    20 mg/2 mL (10 mg/mL) carton label

    NDC 70771-1845-1

    Famotidine Injection USP, 20 mg/2 mL (10 mg/mL)

    FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

    2 mL Single-Dose Vials

    Rx only

    20 mg/2 mL (10 mg/mL) vial label
  • INGREDIENTS AND APPEARANCE
    FAMOTIDINE 
    famotidine injection
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1846
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FAMOTIDINE (UNII: 5QZO15J2Z8) (FAMOTIDINE - UNII:5QZO15J2Z8) FAMOTIDINE40 mg  in 4 mL
    Inactive Ingredients
    Ingredient NameStrength
    ASPARTIC ACID (UNII: 30KYC7MIAI)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    MANNITOL (UNII: 3OWL53L36A)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70771-1846-610 in 1 CARTON02/11/2024
    1NDC:70771-1846-14 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21582802/11/2024
    FAMOTIDINE 
    famotidine injection
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1847
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FAMOTIDINE (UNII: 5QZO15J2Z8) (FAMOTIDINE - UNII:5QZO15J2Z8) FAMOTIDINE200 mg  in 20 mL
    Inactive Ingredients
    Ingredient NameStrength
    ASPARTIC ACID (UNII: 30KYC7MIAI)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    MANNITOL (UNII: 3OWL53L36A)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70771-1847-610 in 1 CARTON02/11/2024
    1NDC:70771-1847-120 mL in 1 VIAL; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21582802/11/2024
    FAMOTIDINE 
    famotidine injection
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1845
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FAMOTIDINE (UNII: 5QZO15J2Z8) (FAMOTIDINE - UNII:5QZO15J2Z8) FAMOTIDINE20 mg  in 2 mL
    Inactive Ingredients
    Ingredient NameStrength
    ASPARTIC ACID (UNII: 30KYC7MIAI)  
    MANNITOL (UNII: 3OWL53L36A)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70771-1845-725 in 1 CARTON02/11/2024
    1NDC:70771-1845-12 mL in 1 VIAL, SINGLE-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21582802/11/2024
    Labeler - Zydus Lifesciences Limited (918596198)
    Establishment
    NameAddressID/FEIBusiness Operations
    Zydus Lifesciences Limited873671928MANUFACTURE(70771-1846, 70771-1847, 70771-1845) , ANALYSIS(70771-1846, 70771-1847, 70771-1845)